We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Protherics | PTI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 45.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 45.00 | 45.00 |
| Top Posts |
|---|
Posted at 21/11/2008 08:50 by bodgit Comments about BTG buying PTI 'on the cheap' seem misplaced. If PTI is 'going cheap' why has not some other big pharma - or anyone else come to that - bought it with their petty cash at a higher price? Why didn't PTI acquire BTG? Why not take the BTG paper and buy more in the market if you think they got it on the cheap. Good luck all. |
Posted at 20/11/2008 08:28 by greekman Results.Financial Highlights, show everything up that should be up and everything down that should be down, except.....Net cash decrease of £9.6m (2007: increase of £6.9m) in line with expectations, providing a cash position of £28.1m (2007: £46.9m) This in the stage of Protherics as a company was/is expected. Who needs BTG. OK it will give PTI more pulling power so to speak, but would still have liked them (PTI) to have chanced going it alone. Yes a big gamble but worth it. In my opinion. BTG have by far the best part of the deal. PTI have sold themselves out far too cheaply. All IMHO of course. |
Posted at 07/11/2008 10:03 by the_doctor armisteadI've not held PTI by the way. However, by not a good outcome, I really meant that most holders would presumably have hoped for more. And IF PTI structured their business properly, could be worth more - but IMO they're throwing too much cash at products that dont all warrant it. The merged PTI-BGC strikes me as a good co though, as you say. |
Posted at 07/11/2008 08:04 by the_doctor I was actually more sceptical that it would be a decent deal for PTI holders. I now think this will probably go through and IMO, it isnt a good outcome. armistead34 - 5 Nov'08 - 17:34 - 8379 of 8382 T-_d: Thanks. I understand you're somewhat sceptical about the merger, and about PTI's prospects? Good to have a contrary voice. Would you care to sktch it out for us? |
Posted at 01/11/2008 20:58 by donk4 stevenparsons - as a BTG holder it is cheaper to buy PTI - if the deal goes through. Say BTG 1.29 divide by 0.291 per btg for pti and you get circa 37.50 pence per pti.This will narrow on the vote being passed imo |
Posted at 07/10/2008 19:27 by gnnmartin My guess is that a fair number of people bought into PTI hoping for a cash bid. They just want a return and out, so they are pulling the price down. On the other side, BTG had had a strong run up from 80p to 240p, and there were a lot of people ready to take profits. And in this market, once people start taking profits, you start hitting stop losses, and the share goes on going down.If PTI and BTG called the whole thing off, I see no reason why PTI shouldn't sink to the price it had before takeover rumours took it up, and then lower still because the market is dire, and nobody like confusion, and anyhow most other things have fallen since then. And again, if PTI and BTG call the whole thing off I don't expect BTG to bounce back. Their bull run has been broken, the domino effect of investors 'protecting profits' (or cutting losses) could well drive the share price further on down. Rational analysis may be trumped by simple fear. Nigel Martin |
Posted at 25/9/2008 13:58 by gnnmartin I reluctantly sold my PTI shares. The problem I see with the BTG bid is that BTG rose from about 85p to 240p in the 6 months to September. While the rise would look justified on fundamentals in normal market conditions, in the current turmoil BTG looked ripe for a setback, and the bid for PTI seems to be the trigger. I guess BTG has been weak since the bid because big PTI shareholders have been selling BTG short to lock in their gain. The two shares look to be trading roughly in line with the proposed scheme at the moment. Any further weakness in BTG relative to PTI might imply a competing interest. The next few weeks up to the 10th Nov. could prove turbulent.Nigel Martin PS. the merger reflects the ratio of the share prices of PTI and BTG at their recent lows, so looks fair to PTI and is good news for anyone who was not hoping for a cash bid. If the market does drive the combined company down to their lows again, they will be a screaming buy for anyone who (unlike me) has money to invest. But that goes for a number of companies at the moment. |
Posted at 18/9/2008 18:36 by cortez Hi DevBod Just lookin at this deal. Digital Look has 342.2m PTI shares in issue, could you confirm? As PTI get 0.291 per PTI share (in new BTG shares), I make that some 117.6m new shares issued but the offer doc say a max of 105.9m new shares will be issued. Also that BTG holders will now own 58.8% of the new company and PTI holders 41.2%. IF BTG's existing 151m shares account for 58.8% of the new shares base then only some 60m new shares will be issued (40% of 150m). I'm baffled as to how many shares they'll actually be. |
Posted at 18/9/2008 18:02 by devbod The directors awarded themselves options a few months ago at 2p a share. They'll at least get pro-rata compensation with BTG options and at most 58p (60p-2p) a share cash. I just checked the announcement but it says that the options are included in the 'Scheme' but its not clear how the compensation will be doen other than it will be 'appropriate'.Who gets what job is described in the RNS, there's a lot of detail there if you scroll down past the standard disclaimers. Although the share price of both companies prior to leaks implies PTI got by far the better half of the deal I'm not happy with the actions of PTI's directors. Cytofab phase II completion in December and Voraxase news could easily have driven PTIs share price back closer to former levels. With any faith in their products and a little less interest in their own pockets PTIs shareholders might have been better served. |
Posted at 08/7/2008 23:32 by cumnor After buying 80000 at 30.5p ish. They are a genuine, albeit small profit making pharma. Sold what I percieve to be more risky shares. In the present enviroment there is too much down side risk and am expecting a few days of capitulation with sps falling across the board but at the same time don't want to be entirely out of the market but that is how i am positioning myself. Even if pti falls (and it will if there is a final shake out) it will recover thanks to it's established products (all decent and money making) and more importantly its cash pile of 35ml plus which in todays market is gold. Small biotechs trying to produce block busters will almost certainly lose money and pti is no different. It's septicimia drug could be a blockbuster with AZs help but the chances are it will fail, as will nearly all of it's early stage products. But the share price i believe is already discounting this scenario and is more than justified by the sales of it's existing products. Because of the risk involved in bringing drugs to market I would like to see PTI abandoning (or outsourcing) it's early stage products and perhaps concentrating on it's septicemia drug which Az is carrying the can for to a decent extent. Voraxaze could be bigger than we expect. I would like to see them using the cash pile instead (with a bit of gearing) to buy some established niche products (drugs or diagnostic) to consolidate their status as a real pharma. In the present climate it is a buyers market and PTI is in a good position. I dont want to see the BOD throwing away cash on high risk early stage products which will almost certainly fail when better options exist. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
